These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1329467)

  • 1. Angiotensin-converting enzyme inhibitors and renal function in heart failure.
    Dietz R; Nagel F; Osterziel KJ
    Am J Cardiol; 1992 Oct; 70(10):119C-125C. PubMed ID: 1329467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of captopril and lisinopril on circadian blood pressure rhythm and renal function in mild-to-moderate heart failure.
    Osterziel KJ; Karr M; Lemmer B; Dietz R
    Am J Cardiol; 1992 Oct; 70(10):147C-150C. PubMed ID: 1329473
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and cardiac function during alpha1-beta-blockade in congestive heart failure.
    Heitmann M; Davidsen U; Stokholm KH; Rasmussen K; Burchardt H; Petersen EB
    Scand J Clin Lab Invest; 2002; 62(2):97-104. PubMed ID: 12004934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal effects of angiotensin-converting enzyme inhibition in cardiac failure.
    Dzau VJ
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):74-80. PubMed ID: 3037893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamic consequences of angiotensin-converting enzyme inhibition in congestive heart failure.
    Suki WN
    Arch Intern Med; 1989 Mar; 149(3):669-73. PubMed ID: 2537612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the first-dose effect of captopril and lisinopril in heart failure.
    Osterziel KJ; Karr M; Busch C; Dietz R
    Am J Cardiol; 1992 Oct; 70(10):137C-139C. PubMed ID: 1329469
    [No Abstract]   [Full Text] [Related]  

  • 10. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system.
    Packer M; Lee WH; Kessler PD
    Circulation; 1986 Oct; 74(4):766-74. PubMed ID: 3019586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral haemodynamic effects of inhibition of prostaglandin synthesis in congestive heart failure and interactions with captopril.
    Townend JN; Doran J; Lote CJ; Davies MK
    Br Heart J; 1995 May; 73(5):434-41. PubMed ID: 7786658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril in heart failure: a double-blind study of the effects on renal function.
    Cleland JG; Dargie HJ; Gillen G; Robertson I; East BW; Ball SG; Morton JJ; Robertson JI
    J Cardiovasc Pharmacol; 1986; 8(4):700-6. PubMed ID: 2427807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal functional alterations induced by angiotensin-converting enzyme inhibitors in heart failure.
    Munger MA
    Ann Pharmacother; 1993 Feb; 27(2):205-10. PubMed ID: 8439700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal function after administration of angiotensin-converting enzyme inhibitors].
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Schweiz Med Wochenschr; 1987 Sep; 117(37):1359-62. PubMed ID: 3672075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    Salah EM; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):205-214. PubMed ID: 29620605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure.
    Packer M
    Cardiology; 1989; 76 Suppl 2():50-5. PubMed ID: 2670221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACE inhibition in heart failure and compromised kidney function].
    Drexler H
    Klin Wochenschr; 1991; 69 Suppl 24():59-64. PubMed ID: 1865634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.
    Cleland JG; Shah D; Krikler S; Dritsas A; Nihoyannopoulos P; Frost G; Oakley CM
    Br Heart J; 1993 Jun; 69(6):512-5. PubMed ID: 8393685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting angiotensin-converting enzyme inhibition: once-daily lisinopril versus twice-daily captopril in mild-to-moderate heart failure.
    Bach R; Zardini P
    Am J Cardiol; 1992 Oct; 70(10):70C-77C. PubMed ID: 1329477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.